Complex Spine & Anterior Skull Base Team, Victor Horsley Department of Neurosurgery, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
University College London (UCL) Medical School, London, UK.
Spinal Cord Ser Cases. 2023 Mar 9;9(1):6. doi: 10.1038/s41394-023-00564-8.
Retrospective case series.
Dorsal root entry zone (DREZ) lesioning can be performed in patients with intractable pain following brachial plexus avulsion (BPA). However, post-operative outcomes are variable and it is uncommonly used. We sought to determine the pain outcomes and complication profile of DREZ lesioning for BPA.
Quaternary neurosurgical centre.
All patients that had undergone DREZ lesioning for BPA pain over a 13-year period were included. Patients were assessed for outcome with regard to degree of pain relief and presence of complications.
Fourteen patients were reviewed, with a median post-operative follow-up duration of 27 months (1-145 months). Of these, ten were contactable for long-term telephone review, with a median post-operative duration of 37 months (11-145 months). At earliest review post-operatively, 12 of 14 patients (86%) had some level of pain relief: complete pain relief in four patients (29%) and partial pain relief in eight patients (57%). At most recent post-operative review, ten of 14 patients (71%) reported lasting significant pain relief: four (29%) had complete pain relief, six (43%) had partial pain relief and four (29%) had insignificant pain relief. Complications were predominantly sensory, including ataxia, hypoaesthesia and dysaesthesia. Four patients (29%) reported persistent motor complications at final follow-up.
DREZ lesioning is uncommonly performed. It remains a reasonable option for relief of refractory BPA pain in selected cases, though there is a significant complication rate. Future prospective studies may enable quantification of pre- and post-lesioning analgesic use, another important determinant of procedure success.
回顾性病例系列。
臂丛神经撕脱伤(BPA)后,顽固性疼痛患者可进行背根入区(DREZ)消融。然而,术后效果不一,且不常用。我们旨在确定 DREZ 消融治疗 BPA 的疼痛结果和并发症情况。
四级神经外科中心。
纳入 13 年来所有因 BPA 疼痛而行 DREZ 消融术的患者。评估患者的疼痛缓解程度和并发症情况。
共 14 例患者接受了回顾,中位术后随访时间为 27 个月(1-145 个月)。其中 10 例可进行长期电话随访,中位术后时间为 37 个月(11-145 个月)。术后最早随访时,14 例患者中有 12 例(86%)有不同程度的疼痛缓解:4 例(29%)完全缓解,8 例(57%)部分缓解。在最近一次术后随访时,14 例患者中有 10 例(71%)报告疼痛持续显著缓解:4 例(29%)完全缓解,6 例(43%)部分缓解,4 例(29%)缓解不明显。并发症主要为感觉障碍,包括共济失调、感觉迟钝和感觉异常。最终随访时,4 例(29%)患者仍有持续性运动并发症。
DREZ 消融术不常用。在某些情况下,它仍然是治疗难治性 BPA 疼痛的合理选择,但并发症发生率较高。未来的前瞻性研究可能能够量化术前和术后的镇痛使用情况,这也是手术成功的另一个重要决定因素。